Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Chinese Patent Office
Baxter
AstraZeneca
Citi
McKesson
Federal Trade Commission
Teva
McKinsey

Generated: May 27, 2018

DrugPatentWatch Database Preview

HYDROPRES 25 Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Hydropres 25, and what generic alternatives are available?

Hydropres 25 is a drug marketed by Merck and is included in one NDA.

The generic ingredient in HYDROPRES 25 is hydrochlorothiazide; reserpine. There are thirty-two drug master file entries for this compound. Additional details are available on the hydrochlorothiazide; reserpine profile page.
Summary for HYDROPRES 25
Drug patent expirations by year for HYDROPRES 25
Synonyms for HYDROPRES 25
C33H40N2O9.C7H8ClN3O4S2
H.R.-50
HYDRO-SERP "25"
HYDRO-SERP "50"
HYDROCHLOROTHIAZIDE W/ RESERPINE
HYDROCHLOROTHIAZIDE; RESERPINE
LS-178646
RESERPINE AND HYDROCHLOROTHIAZIDE
RESERPINE AND HYDROCHLOROTHIAZIDE-50
SCHEMBL4265419

US Patents and Regulatory Information for HYDROPRES 25

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck HYDROPRES 25 hydrochlorothiazide; reserpine TABLET;ORAL 011958-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Johnson and Johnson
Chinese Patent Office
Fish and Richardson
UBS
Medtronic
Cerilliant
US Army
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.